This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Akhrass, F. Articles by Mazzone, T. Search for Related Content PubMed PubMed Citation Articles by Akhrass, F. Articles by Mazzone, T.

Hormone Replacement Therapy Is Associated with Less Coronary Atherosclerosis in Postmenopausal Women

Rush-Presbyterian-St. Luke’s Medical Center (F.A., A.T.E., S.R., C.R.K., L.F., T.M.), Chicago, Illinois 60612; and John H. Stroger, Jr., Hospital of Cook County (A.T.E., Y.W., L.F.), Chicago, Illinois 60612

Address all correspondence and requests for reprints to: Theodore Mazzone, M.D., University of Illinois, 1819 West Polk, M/C 797, Chicago, Illinois 60612. E-mail: tmazzone{at}uic.edu.

Most observational studies indicate that hormone replacement therapy (HRT) protects women from cardiovascular disease. Two recent randomized trials, however, showed no reduction in coronary events with HRT in postmenopausal women. A randomized study evaluating subclinical atherosclerosis showed a beneficial effect of estrogen. In the current study we evaluated the association between HRT and coronary artery atherosclerosis, as quantified by coronary artery calcium score. Current users of HRT were significantly more likely to have a coronary artery calcium score less than 100 and were less likely to have a score greater than 400 than non-HRT users. After adjustment for cardiac risk factors, current use of HRT was associated with a significant reduction of coronary artery calcium score (-28; 95% confidence interval, -48 to -10). The average age of users was 59 yr, the mean duration of use was 9 yr, and the duration of HRT use was significantly associated with a reduction in coronary artery calcium. These results suggest that HRT suppresses atherosclerosis in the coronary arteries. The failure to modify the cardiovascular event rate in clinical trials could result from the adverse effect of HRT on complicated lesions. Additional mechanistic studies may help identify therapeutic strategies that could maximize a potential benefit of HRT on early atherogenesis while minimizing adverse proinflammatory and procoagulant effects on complicated plaque lesions.

Abbreviations: CAC, Coronary artery calcium; CHD, coronary heart disease; EBT, electron beam tomography; HRT, hormone replacement therapy; WHI, Women’s Health Initiative.

This article has been cited by other articles:

				M. L. Power, J. Baron, and J. Schulkin Factors Associated with Obstetrician-Gynecologists' Response to the Women's Health Initiative Trial of Combined Hormone Therapy Med Decis Making, June 1, 2008; 28(3): 411 - 418. [Abstract] [PDF]

				J. E. Manson, M. A. Allison, J. E. Rossouw, J. J. Carr, R. D. Langer, J. Hsia, L. H. Kuller, B. B. Cochrane, J. R. Hunt, S. E. Ludlam, et al. Estrogen Therapy and Coronary-Artery Calcification N. Engl. J. Med., June 21, 2007; 356(25): 2591 - 2602. [Abstract] [Full Text] [PDF]

				R. C. Christian, P. Y. Liu, S. Harrington, M. Ruan, V. M. Miller, and L. A. Fitzpatrick Intimal Estrogen Receptor (ER){beta}, But Not ER{alpha} Expression, Is Correlated with Coronary Calcification and Atherosclerosis in Pre- and Postmenopausal Women J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2713 - 2720. [Abstract] [Full Text] [PDF]

				S M. HARMAN, F. NAFTOLIN, E. A. BRINTON, and D. R. JUDELSON Is the Estrogen Controversy Over? Deconstructing the Women's Health Initiative Study: A Critical Evaluation of the Evidence Ann. N.Y. Acad. Sci., June 1, 2005; 1052(1): 43 - 56. [Abstract] [Full Text] [PDF]

				R. H. Mackey, L. H. Kuller, K. Sutton-Tyrrell, R. W. Evans, R. Holubkov, and K. A. Matthews Hormone Therapy, Lipoprotein Subclasses, and Coronary Calcification: The Healthy Women Study Arch Intern Med, March 14, 2005; 165(5): 510 - 515. [Abstract] [Full Text] [PDF]

				A. Cederholm, E. Svenungsson, K. Jensen-Urstad, C. Trollmo, A.-K. Ulfgren, J. Swedenborg, G.-Z. Fei, and J. Frostegard Decreased Binding of Annexin V to Endothelial Cells: A Potential Mechanism in Atherothrombosis of Patients With Systemic Lupus Erythematosus Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 198 - 203. [Abstract] [Full Text] [PDF]

				M. Abedin, Y. Tintut, and L. L. Demer Vascular Calcification: Mechanisms and Clinical Ramifications Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1161 - 1170. [Abstract] [Full Text] [PDF]

				L. A. Fitzpatrick Hormones and the Heart: Controversies and Conundrums J. Clin. Endocrinol. Metab., December 1, 2003; 88(12): 5609 - 5610. [Full Text] [PDF]